• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活体肾供者是如何发展为终末期肾病的?

How do living kidney donors develop end-stage renal disease?

作者信息

Kido R, Shibagaki Y, Iwadoh K, Nakajima I, Fuchinoue S, Fujita T, Teraoka S

机构信息

Department of Nephrology and Endocrinology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.

出版信息

Am J Transplant. 2009 Nov;9(11):2514-9. doi: 10.1111/j.1600-6143.2009.02795.x. Epub 2009 Aug 14.

DOI:10.1111/j.1600-6143.2009.02795.x
PMID:19681812
Abstract

The clinical course and risk factors for developing end-stage renal disease (ESRD) after heminephrectomy in living kidney donors have scarcely been investigated. We reviewed medical records and identified eight case donors who developed chronic kidney disease (CKD) stage 5 or ESRD, and subsequently investigated the association between postoperative clinical courses and changes in renal function. To conduct a case-control study, we also selected a control group comprising 24 donors who had maintained stable renal function and were matched for age, sex and follow-up time since donation. Except for one donor who developed ESRD caused by a traffic accident, none of the donors developed progressive renal dysfunction immediately after donation. Their renal functions remained stable for a long period of time, but started to decline after developing new comorbidities, especially risk factors known as progression factors (proteinuria or hypertension) or accelerating factors (cardiovascular [CV] event or infection) of CKD. As compared with the control donors, incidence of postoperative persistent proteinuria, acute CV event, severe infection and hospitalization due to accelerating factors of CKD were significantly higher in the case donors. These results suggest the importance of long-term (more than 10 years) follow-up of donors with special attention on the risk factors of CKD.

摘要

活体肾供体半肾切除术后发生终末期肾病(ESRD)的临床病程及危险因素鲜有研究。我们回顾了病历,确定了8例发展为慢性肾脏病(CKD)5期或ESRD的供体病例,随后研究了术后临床病程与肾功能变化之间的关联。为进行病例对照研究,我们还选取了一个由24名肾功能保持稳定的供体组成的对照组,这些供体在年龄、性别及捐献后的随访时间方面相匹配。除1例因交通事故导致ESRD的供体外,其他供体在捐献后均未立即出现进行性肾功能障碍。他们的肾功能在很长一段时间内保持稳定,但在出现新的合并症后开始下降,尤其是那些已知的CKD进展因素(蛋白尿或高血压)或加速因素(心血管[CV]事件或感染)。与对照供体相比,病例供体术后持续性蛋白尿、急性CV事件、严重感染以及因CKD加速因素住院的发生率显著更高。这些结果表明对供体进行长期(超过10年)随访并特别关注CKD危险因素的重要性。

相似文献

1
How do living kidney donors develop end-stage renal disease?活体肾供者是如何发展为终末期肾病的?
Am J Transplant. 2009 Nov;9(11):2514-9. doi: 10.1111/j.1600-6143.2009.02795.x. Epub 2009 Aug 14.
2
Causes and timing of end-stage renal disease after living kidney donation.活体肾捐献后终末期肾病的病因和发生时间。
Am J Transplant. 2018 May;18(5):1140-1150. doi: 10.1111/ajt.14671. Epub 2018 Mar 1.
3
Increasing Use of the Expanded Criteria for Living Kidney Donation and Good Outcomes of Living Kidney Donors in Korea.韩国扩大标准活体肾捐赠的使用增加及活体肾捐赠者的良好结局
Transplant Proc. 2016 Sep;48(7):2407-2411. doi: 10.1016/j.transproceed.2016.02.091.
4
Association of Early Postdonation Renal Function With Subsequent Risk of End-Stage Renal Disease in Living Kidney Donors.早期捐肾后肾功能与活体肾供者终末期肾病风险的关联。
JAMA Surg. 2020 Mar 1;155(3):e195472. doi: 10.1001/jamasurg.2019.5472. Epub 2020 Mar 18.
5
Renal Consequences of Diabetes After Kidney Donation.肾移植后糖尿病的肾脏后果。
Am J Transplant. 2017 Dec;17(12):3141-3148. doi: 10.1111/ajt.14416. Epub 2017 Aug 14.
6
End-stage renal disease among living-kidney donors: single-center experience.活体肾供者中的终末期肾病:单中心经验
Exp Clin Transplant. 2011 Feb;9(1):14-9.
7
Renal Function Profile in White Kidney Donors: The First 4 Decades.白种肾供者的肾功能概况:最初的40年。
J Am Soc Nephrol. 2016 Sep;27(9):2885-93. doi: 10.1681/ASN.2015091018. Epub 2016 Feb 17.
8
Long-term outcomes of living kidney donors over the past 28 years in a single center in Taiwan.台湾某单一中心过去28年活体肾供者的长期结局
Transplant Proc. 2012 Jan;44(1):39-42. doi: 10.1016/j.transproceed.2011.12.024.
9
Obesity increases the risk of end-stage renal disease among living kidney donors.肥胖会增加活体肾供者发生终末期肾病的风险。
Kidney Int. 2017 Mar;91(3):699-703. doi: 10.1016/j.kint.2016.10.014. Epub 2016 Dec 29.
10
Risk of end-stage renal disease following live kidney donation.活体肾捐献后终末期肾病的风险。
JAMA. 2014 Feb 12;311(6):579-86. doi: 10.1001/jama.2013.285141.

引用本文的文献

1
Screening and prognostic roles of renal volumetry and scintigraphy in the assessment of living kidney transplant donors, considering the early recovery of the residual renal function.考虑到残余肾功能的早期恢复,肾脏容积测量和闪烁扫描在活体肾移植供体评估中的筛查和预后作用。
BMC Nephrol. 2025 Jan 17;26(1):28. doi: 10.1186/s12882-024-03850-1.
2
Follow-up After Donor Nephrectomy in Living Kidney Donors: How to Manage Living Kidney Donors Postoperatively.活体供肾者肾切除术后随访:如何对活体供肾者术后进行管理。
In Vivo. 2024 Jul-Aug;38(4):1900-1910. doi: 10.21873/invivo.13645.
3
Consequences of low estimated glomerular filtration rate either before or early after kidney donation.
供体捐献前或早期估算肾小球滤过率低的后果。
Am J Transplant. 2024 Oct;24(10):1816-1827. doi: 10.1016/j.ajt.2024.04.023. Epub 2024 Jun 14.
4
Risk Factors for Developing Low Estimated Glomerular Filtration Rate and Albuminuria in Living Kidney Donors.活体肾供体发生低估算肾小球滤过率和蛋白尿的危险因素。
Kidney Med. 2023 Dec 4;6(2):100767. doi: 10.1016/j.xkme.2023.100767. eCollection 2024 Feb.
5
Long-term Medical Outcomes of Living Kidney Donors.活体肾移植供者的长期医疗结果。
Mayo Clin Proc. 2022 Nov;97(11):2107-2122. doi: 10.1016/j.mayocp.2022.06.013. Epub 2022 Oct 7.
6
Long-term risk of all-cause mortality in live kidney donors: a matched cohort study.活体肾供者全因死亡的长期风险:一项匹配队列研究。
Kidney Res Clin Pract. 2022 Jan;41(1):102-113. doi: 10.23876/j.krcp.21.042. Epub 2021 Nov 5.
7
GFR ≤25 years postdonation in living kidney donors with (vs. without) a first-degree relative with ESRD.在有(无)一级亲属患有 ESRD 的活体肾捐献者中,GFR 在捐肾后 25 年内≤。
Am J Transplant. 2018 Mar;18(3):625-631. doi: 10.1111/ajt.14525. Epub 2017 Dec 1.
8
Renal Consequences of Diabetes After Kidney Donation.肾移植后糖尿病的肾脏后果。
Am J Transplant. 2017 Dec;17(12):3141-3148. doi: 10.1111/ajt.14416. Epub 2017 Aug 14.
9
Cystatin-C is associated with partial recovery of kidney function and progression to chronic kidney disease in living kidney donors: Observational study.胱抑素C与活体肾供者肾功能的部分恢复及进展为慢性肾脏病相关:一项观察性研究。
Medicine (Baltimore). 2017 Feb;96(5):e6037. doi: 10.1097/MD.0000000000006037.
10
Follow-up rates of living kidney donor in Japan: A single center study.日本活体肾供者的随访率:一项单中心研究。
Indian J Nephrol. 2016 Nov-Dec;26(6):423-426. doi: 10.4103/0971-4065.172229.